Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Pulmatrix (PULM) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 27 quarters since 2014. Compare with PULM stock chart to see long term trends.

PULM stock compared to

PULM Income Statement

Revenue, Net:2000000
Revenue Per Share:0.07
Research & Development Expense:3265000
Total Operating Expenses:4674000
Operating Income:-2674000
Net Income:-2899000
Earnings Per Share, Basic:-0.08
Shares Outstanding, Basic Avg:28753310

PULM Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:58000
Change in Accounts Receiveable:-1133000
Net Cash from Operations:-2768000
Net Cash from Financing Activities:0
Property, Plant & Equipment Purchases:83000
Net Cash from Investing Activities:-83000
Net Change in Cash & Equivalents:-2851000

PULM Balance Sheet

Cash and Cash Equivalents:31861000
Accounts Receivable, Net:84000
Total Current Assets:32538000
Property, Plant & Equipment, Net:361000
Total Assets:38169000
Accounts Payable:925000
Total Short-Term Liabilities:8254000
Total Liabilities:15030000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Renaissance Technologies LLC
1,993,969 sh
318,636 sh
19%
$2,373
-$509
Sabby Management, LLC
1,740,663 sh
1,728,719 sh
14474%
$2,071
$2,050
Vanguard Group Inc
1,602,415 sh
33,613 sh
2%
$1,907
-$791
Blackrock Inc.
104,918 sh
8,573 sh
9%
$125
-$41
Paloma Partners Management Co
59,185 sh
59,185 sh
NEW
$70
$70
Northern Trust Corp
33,965 sh
 
$40
Royal Bank Of Canada
8,196 sh
8,196 sh
NEW
$10
$10
Glenmede Trust Co Na
2,200 sh
-400 sh
-15%
$2
-$2
Morgan Stanley
1,951 sh
1,951 sh
NEW
$2
$2
Bank Of America Corp /De/
979 sh
9 sh
1%
$1
-$1
Virtu Financial LLC
0 sh
-93,209 sh
-100%
$0
-$160
Goldman Sachs Group Inc
0 sh
-30,550 sh
-100%
$0
-$53
Proequities, Inc.
0 sh
 
$0

Data imported from Pulmatrix Inc SEC filings. Check original filings before making any investment decision.